Inspiremd Stock Investor Sentiment

NSPR Stock  USD 2.77  0.06  2.21%   
Slightly above 54% of InspireMD's retail investors are presently thinking to get in. The analysis of overall sentiment of trading InspireMD stock suggests that some investors are interested at this time. InspireMD's investing sentiment overview a quick insight into current market opportunities from investing in InspireMD. Many technical investors use InspireMD stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  

InspireMD Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards InspireMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at globenewswire.com         
InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Mo...
Macroaxis News: globenewswire.com
over a year ago at news.google.com         
InspireMDs investors will be pleased with their impressive 179 percent return over the last year - Y...
Google News at Macroaxis
over a year ago at finance.yahoo.com         
InspireMDs investors will be pleased with their impressive 179 percent return over the last year
Yahoo News
over a year ago at news.google.com         
InspireMD Supports CMS Final National Coverage Determination Expanding Coverage of Carotid Stenting ...
Google News at Macroaxis
over a year ago at benzinga.com         
InspireMD Supports CMS Final National Coverage Determination Expanding Coverage of Carotid Stenting ...
benzinga news
over a year ago at finance.yahoo.com         
InspireMD Supports CMS Final National Coverage Determination Expanding Coverage of Carotid Stenting ...
Yahoo News
over a year ago at www.macroaxis.com         
InspireMD exotic insider transaction detected
Macroaxis News
over a year ago at news.google.com         
InspireMD Announces Senior Leadership Changes to Support ... - GlobeNewswire
Google News at Macroaxis
over a year ago at finance.yahoo.com         
InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives
Yahoo News
over a year ago at news.google.com         
By 2030 Carotid Stent Market Business Expansion Exclusive Analysis - Benzinga
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Favourable Signals For InspireMD Numerous Insiders Acquired Stock
Yahoo News
over a year ago at news.google.com         
Carotid Artery Stents Market Share, Industry Size, Leading Companies Outlook, Upcoming Challenges an...
Google News at Macroaxis
over a year ago at news.google.com         
Insider Returns Down To US374k As InspireMDs Stock Dips 11 percent - Simply Wall St
Google News at Macroaxis
over a year ago at simplywall.st         
Insider Returns Down To US374k As InspireMDs Stock Dips 11
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
Endovascular Therapy Device Market research Report with Analysis 2023 To 2030 Report Pages 110 - Ben...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about InspireMD that are available to investors today. That information is available publicly through InspireMD media outlets and privately through word of mouth or via InspireMD internal channels. However, regardless of the origin, that massive amount of InspireMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of InspireMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of InspireMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to InspireMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive InspireMD alpha.

InspireMD Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635
11/08/2024
2
InspireMD GAAP EPS of -0.16, revenue of 1.81M beats by 0.07M
11/12/2024
3
InspireMD, Inc. Q3 2024 Earnings Call Transcript
11/13/2024
4
InspireMD Third Quarter 2024 Earnings US0.16 loss per share
11/14/2024
5
Insider Trading
11/25/2024
6
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization ...
12/09/2024
7
InspireMD, Inc. CFO Craig Shore to Retire, Company Initiates Search for SuccessorDecember 12, 2024-
12/12/2024
8
Acquisition by Roubin Gary S of 30625 shares of InspireMD at 1.3827 subject to Rule 16b-3
12/27/2024

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.